Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CRSP is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
63 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 6 days ago
Red flags: 2
523 filers reported a long position in CRSP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARK Investment Management LLC | $516M | 9.5M | -16.4% |
| BlackRock, Inc. | $455.4M | 8.3M | +8.7% |
| Orbis Allan Gray Ltd | $297.2M | 5.4M | -10.8% |
| Capital World Investors | $259M | 4.7M | +0.5% |
| STATE STREET CORP | $235.7M | 4.3M | +8.5% |
| GSK plc | $175.7M | 3.2M | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $136.9M | 2.5M | +5.6% |
| T. Rowe Price Investment Management, Inc. | $112M | 2.1M | -30.5% |
| SR ONE CAPITAL MANAGEMENT, LP | $111.2M | 2M | Unchanged |
| TWO SIGMA INVESTMENTS, LP | $108.5M | 2M | +34.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.